AstraZeneca to leverage its capabilities to boost US renewable natural gas productivity
Expanded collaboration with Vanguard Renewables aims to significantly increase the productivity of US renewable natural gas generation
Expanded collaboration with Vanguard Renewables aims to significantly increase the productivity of US renewable natural gas generation
The company will manufacture a cancer immunotherapy product from 2022
The investment programme is expected to significantly reduce commercialisation lead times, costs and introduce more sustainable manufacturing processes
Subscribe To Our Newsletter & Stay Updated